Temsamani Karim Saad

CIK 00019444911 companyATLANTA, GA

SEC Profile

Transactions

Companies

Filings

CIK

0001944491

Recent Transactions

32 trades

Sale
Cardlytics, Inc.$CDLX
Common Stock
2024-06-04$8.65/sh−43,129→ 385,530 total
Exercise/Conversion
Cardlytics, Inc.$CDLX
Restricted Stock Unit
2024-06-01−84,079→ 756,710 total
Exercise/Conversion
Cardlytics, Inc.$CDLX
Common Stock
2024-06-01+84,079→ 428,659 total
Sale
Cardlytics, Inc.$CDLX
Common Stock
2024-04-02$13.69/sh−32,564→ 344,734 total
Exercise/Conversion
Cardlytics, Inc.$CDLX
Restricted Stock Unit
2024-04-01−50,000→ 0 total
Exercise/Conversion
Cardlytics, Inc.$CDLX
Common Stock
2024-04-01+50,000→ 377,298 total
Sale
Cardlytics, Inc.$CDLX
Common Stock
2024-04-01$14.41/sh−154→ 344,580 total
Award
Cardlytics, Inc.$CDLX
Restricted Stock Unit
2024-03-22+300,000→ 300,000 total
Sale
Cardlytics, Inc.$CDLX
Common Stock
2024-03-04$7.89/sh−34,515→ 327,298 total
Exercise/Conversion
Cardlytics, Inc.$CDLX
Restricted Stock Unit
2024-03-01−84,078→ 840,789 total
Exercise/Conversion
Cardlytics, Inc.$CDLX
Common Stock
2024-03-01+84,078→ 361,813 total
Sale
Cardlytics, Inc.$CDLX
Common Stock
2024-01-03$7.77/sh−31,123→ 277,735 total
Exercise/Conversion
Cardlytics, Inc.$CDLX
Common Stock
2024-01-01+50,000→ 308,858 total
Exercise/Conversion
Cardlytics, Inc.$CDLX
Restricted Stock Unit
2024-01-01−50,000→ 50,000 total
Sale
Cardlytics, Inc.$CDLX
Common Stock
2023-12-05$8.21/sh−40,413→ 258,858 total
Exercise/Conversion
Cardlytics, Inc.$CDLX
Restricted Stock Unit
2023-12-01−84,079→ 924,867 total
Exercise/Conversion
Cardlytics, Inc.$CDLX
Common Stock
2023-12-01+84,079→ 299,271 total
Sale
Cardlytics, Inc.$CDLX
Common Stock
2023-10-02$16.35/sh−106→ 215,192 total
Sale
Cardlytics, Inc.$CDLX
Common Stock
2023-10-02$14.92/sh−8,299→ 220,006 total
Sale
Cardlytics, Inc.$CDLX
Common Stock
2023-10-02$15.70/sh−4,708→ 215,298 total
Sale
Cardlytics, Inc.$CDLX
Common Stock
2023-10-02$13.55/sh−15,463→ 228,305 total
Exercise/Conversion
Cardlytics, Inc.$CDLX
Restricted Stock Units
2023-10-01−50,000→ 100,000 total
Exercise/Conversion
Cardlytics, Inc.$CDLX
Common Stock
2023-10-01+50,000→ 243,768 total
Sale
Cardlytics, Inc.$CDLX
Common Stock
2023-09-08$17.71/sh−81,542→ 193,768 total
Sale
Cardlytics, Inc.$CDLX
Common Stock
2023-09-07$16.90/sh−85,431→ 275,310 total
Exercise/Conversion
Cardlytics, Inc.$CDLX
Restricted Stock Unit
2023-09-01−336,315→ 1,008,946 total
Exercise/Conversion
Cardlytics, Inc.$CDLX
Common Stock
2023-09-01+336,315→ 360,741 total
Sale
Cardlytics, Inc.$CDLX
Common Stock
2023-07-03$6.13/sh−25,574→ 24,426 total
Exercise/Conversion
Cardlytics, Inc.$CDLX
Restricted Stock Unit
2023-07-01−50,000→ 150,000 total
Exercise/Conversion
Cardlytics, Inc.$CDLX
Common Stock
2023-07-01+50,000→ 50,000 total
Award
Cardlytics, Inc.$CDLX
Restricted Stock Units
2023-04-05+200,000→ 200,000 total
Award
Cardlytics, Inc.$CDLX
Restricted Stock Unit
2022-09-01+1,345,261→ 1,345,261 total

Companies

Cardlytics, Inc.
Director, Chief Executive Officer
$CDLX

Recent Filings

Address

675 PONCE DE LEON AVE. NE SUITE 6000

ATLANTA, GA, 30308

View on SEC.gov